More in Medical Device Tax

  • Jan 30, 2013
    blog

    Despite efforts to repeal tax, manufacturers make first semimonthly $97 Million medical device tax payment

    It was a race against time, and the device manufacturers appear to have lost. At least for now. A coalition of medical device manufacturers said that yesterday's first semimonthly payment of approximately $97 million to the IRS for the medical device tax ......More
  • Jan 2, 2013
    blog

    Fiscal cliff package won't diminish opposition to medical device tax, says AdvaMed

    In case you're wondering how the "fiscal cliff" legislation will impact efforts to repeal the medical device tax, you'll want to read the following statement issued this morning by Stephen J. Ubl, president and CEO of AdvaMed:   “The effort to ......More
  • Sep 11, 2012
    blog

    AdvaMed responds to hearing on IRS's implementation of device tax

    AdvaMed President and CEO Stephen Ubl released the following statement today regarding the House Subcommittee on Oversight of the Committee on Ways and Means hearing on the medical device excise tax's implementation and administration: While ......More
  • Jul 19, 2012
    blog

    AdvaMed's Ubl weighs in on tax reform for hearing before House before Ways and Means Committee

    The following is the written testimony from AdvaMed President and CEO Steve Ubl submitted to the House Ways and Means Committee for the July19th hearing on tax reform and the manufacturing sector  Thank you for the opportunity to submit testimony ......More
  • Jun 8, 2012
    blog

    House passes bill to repeal medical device excise tax; hailed as a 'vote to protect jobs and encourage innovation'

    The “Healthcare Costs Reduction Act” passed today on the floor of the House of Representatives by a bipartisan vote of 270 to 146. The bill, sponsored by Rep. Erik Paulsen (R-MN), would repeal the $29 billion tax on American medical device companies that ......More
  • Jun 6, 2012
    blog

    Broad coalition urges House of Representatives to repeal medical device tax

    The fight for repeal of the medical device excise tax gain has continued to gain momentum. As the US House of Representatives gets set to vote on legislation that will repeal the 2.3% excise tax, a broad coalition of medical technology companies and ......More
  • Jun 1, 2012
    blog

    Ways and Means Committee approves legislation to repeal device tax

    The US House of Representatives Ways and Means Committee has approved legislation that will repeal the 2.3% excise tax from the Internal Revenue Code of 1986. It was one of four healthcare-related bills that passed with bipartisan support. The bill, ......More
  • May 8, 2012
    blog

    AdvaMed to IRS: dated excise tax structure won't work for medical device industry

    While AdvaMed remains committed to advocating for the repeal of the medical device excise tax (MDET), the association is also devoting time and energy to making sure that if implemented, the tax is as palatable as possible. In a press conference ......More
  • Apr 24, 2012
    blog

    LinkedIn group creates online petition to kill device tax

    A new Web site has sprung up to gather signatures to petition the repeal of the medical device tax. Created by the LinkedIn Medical Devices Group, the "No 2.3%" Web site is a grassroots effort that needs 23,465 signatures by July 18. (As of April 24, it ......More
  • Mar 27, 2012
    blog

    New study shows device tax may deal economic deathblow to medtech industry

    A significant change to the US advanced medical technology industry's operating environment—such as the soon-to-be-implemented medical device excise tax—could cost tens of thousands of jobs, lower personal incomes, and reduce business opportunities ......More
  • Mar 22, 2012
    Commentary

    Medtech stocks would improve with repeal of health reform, says analyst

    "Since we believe the negatives from reform significantly outweigh the positives, we think med tech stocks would move higher if the Supreme Court repealed health reform," says Michael Matson, senior equity research analyst and executive director for ......More

Sponsored Introduction Continue on to (or wait seconds) ×